The Medicines (Products for Human Use) (Fees) Regulations 2013 (revoked)

1. Introductory Text

2. PART 1 General

   1. 1. Citation and commencement

   2. 2. Interpretation

3. PART 2 Capital Fees for Pre-Application Meetings

   1. 3. Interpretation of Part 2

   2. 4. Fee for scientific advice: application for, or variation to, EU marketing authorisation

   3. 5. Fee for scientific advice: classification of a medicinal product

   4. 6. Fee for advertising advice

   5. 7. Fee for pharmacovigilance advice

   6. 8. Fee for advice on labelling or leaflets

   7. 9. Fee for regulatory advice

   8. 10. Fee for advice for other purposes

   9. 11. Time for payment of fees under regulations 4 to 10

4. PART 3 Capital Fees for Applications for Authorisations, Registrations, Licences or Certificates and for Associated Inspections

   1. 12. Fees for applications for authorisations, registrations, licences or certificates etc.

   2. 13. Fee for applications for additional copy certificates

   3. 14. Fees for applications for certificates and copy certificates by exporters of medicinal products

5. PART 4 Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States

   1. 15. Meaning of “set of applications”

   2. 16. Fees for applications for regulatory assistance under the mutual recognition procedure

   3. 17. Time for payment of fees under regulation 16

6. PART 5 Capital Fees for Applications for Variations of Authorisations, Registrations and Licences and for Associated Compliance Activities

   1. 18. Fees for variations of authorisations, registrations and licences

   2. 19. Fees for amendments to clinical trial authorisations

   3. 20. Fees for notification of changes and reports for broker's registrations

   4. 21. Fees for notification of changes and compliance Reports for active substance registrations

   5. 22. Applications for multiple variations

7. PART 6 Capital Fees for Assessment of Labels and Leaflets

   1. 23. Meaning of “set of proposed changes”

   2. 24. Fees for assessment of a set of proposed changes to labels and leaflets

   3. 25. Time for payment of fees under regulation 24

8. PART 7 Capital Fees for Applications for Renewals of Certain Licences, Authorisations and Registrations and for Associated Inspections

   1. 26. Fees for renewals of certain manufacturer's licences

   2. 27. Fees for renewals in terms which are not identical to the existing authorisation, licence or registration

9. PART 8 Capital Fees for Regulatory Assistance Given by the United Kingdom Acting as Reference Member State Relating to the Assessment of Applications for the Renewal of Specified Marketing Authorisations

   1. 28. Fees for regulatory assistance for certain marketing authorisations

10. PART 9 Capital Fees for Inspections

    1. 29. Fees for inspections

    2. 30. Fees for inspections of pharmacovigilance service providers

    3. 31. Payer of inspection fee (contract laboratories and API manufacturing sites)

    4. 32. Inspections in connection with multiple applications

    5. 33. Fees for inspections relating to good clinical practice in clinical trials

    6. 34. Amount, and time for payment, of inspection fees in respect of an application for a wholesale dealer's licence

    7. 35. Adjustment and refund of inspection fees in respect of a wholesale dealer's licence

    8. 36. Amount, and time for payment, of inspection fees in respect of an application for a broker's registration or an active substance registration

11. PART 10 Periodic Fees for Authorisations, Registrations and Licences

    1. 37. Periodic fees

12. PART 11 Capital Fees for Application for Membership of Good Clinical Practice Accreditation Scheme and for Certificate of Membership

    1. 38. Meaning of “good clinical practice accreditation scheme”

    2. 39. Fees for applications for membership and certificates

13. PART 12 Capital Fee for a Review Upon Oral Representations or a Person Appointed Hearing

    1. 40. Fee for a review upon oral representations or a person appointed hearing

    2. 41. Time for payment under regulation 40

14. PART 13 Fees in relation to the Part 6 of the Human Medicines Regulations (certification of homoeopathic medicinal products)

    1. 42. Interpretation

    2. 43. Fees for applications made at the invitation of the licensing authority

    3. 44. Fees for applications for certificates

    4. 45. Fees for variations of certificates

    5. 46. Time for payment of fees

15. PART 14 Administration

    1. 47. Payment of fees to Ministers

    2. 48. Time for payment of capital fees in connection with applications or inspections

    3. 49. Time for payment of capital fees – applications made by small companies

    4. 50. Payment of fees in respect of a traditional herbal registration

    5. 51. Time for payment of periodic fees

    6. 52. Penalty fees for late payment of periodic fees

    7. 53. Daily penalty fees for late payment of periodic fees

    8. 54. Refund or waiver of fees under regulation 52 or 53

    9. 55. Adjustment, waiver, reduction or refund of fees

    10. 56. Suspension of licences and authorisations

    11. 57. Civil proceedings to recover unpaid fees

16. PART 15 Consequential Amendments

    1. 58. Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004

17. PART 16 Revocations and Savings

    1. 59. The Medicines (Products for Human Use) (Fees) Regulations 2012

    2. 60. The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2012

    3. 61. Other Revocations

18. Signature

19. SCHEDULES

    1. SCHEDULE 1

       General interpretation provisions

       1. 1. In these Regulations, unless the context requires otherwise— “the 2001...

       2. 2. For the purposes of these Regulations, a clinical trial authorisation...

       3. 3. In these Regulations any reference to an application for the...

    2. SCHEDULE 2

       Capital fees for applications for, and variations to, marketing authorisations, licences, registrations and certificates

       1. PART 1 General: interpretation and categories of applications and variations

          1. 1. Interpretation

          2. 2. General: categories of applications and variations

          3. 3. Administrative variation application

          4. 4. Extension application

          5. 5. Complex application

          6. 6. Complex registration application

          7. 7. Complex variation application

          8. 8. Decentralised procedure application

          9. 9. Extended Type II Complex Variation Application

          10. 10. Major application

          11. 11. Mutual recognition procedure incoming application

          12. 12. New excipient variation application

          13. 13. New indication variation application

          14. 14. Parallel import licence application

          15. 15. Reclassification variation application

          16. 16. Reduced registration application

          17. 17. Simple application

          18. 18. Standard application

          19. 19. Standard registration application

          20. 20. Standard variation application

          21. 21. Standard variation application for a homoeopathic medicinal product

          22. 22. Type IB and Type II Applications

          23. 23. Type II Complex Variation Application

       2. PART 2 Capital Fees for Applications for Authorisations, Licences, Registrations and Certificates

          1. 24. Marketing authorisations

          2. 25. Fees where application includes reclassification

          3. 26. Fees where person holds clinical trial certificate

          4. 27. Joint development

          5. 28. Application for multiple authorisations

          6. 29. Authorisation for a national homoeopathic product

          7. 30. Manufacturer's licences and authorisations

          8. 31. Wholesale dealer's licences

          9. 32. Broker's registrations

          10. 33. Active substance registrations

          11. 34. Clinical trial authorisations

          12. 35. Traditional herbal registrations

       3. PART 3 Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States

          1. 36. Outgoing mutual recognition applications

       4. PART 4 Capital Fees for Applications for Variations of Authorisations, Licences and Registrations

          1. 37. Marketing authorisations

          2. 38. Variation of marketing authorisations

          3. 39. Reclassification of marketing authorisations

          4. 40. Variation of marketing authorisation: national homoeopathic products

          5. 41. Variation of parallel import licence

          6. 42. Manufacturer's authorisations and licences

          7. 43. Variation of manufacturer's authorisations and licences

          8. 44. Wholesale dealer's licences

          9. 45. Variation of wholesale dealer's licence

          10. 46. Variation of a broker's registration

          11. 47. Variation of an active substance registration

          12. 48. Clinical trial authorisations

          13. 49. Traditional herbal registrations

          14. 50. Identical variations

          15. 51. Complex Variation Applications

          16. 52. Multiple reclassification variation applications

       5. PART 5 Capital Fees for Assessment of Labels and Leaflets

          1. 53. A set of changes

          2. 54. More than one set of changes proposed

       6. PART 6 Capital Fees for Regulatory Assistance Given by the United Kingdom Acting as Reference Member State Relating to the Assessment of Applications for the Renewal of Specified Marketing Authorisations

          1. 55. Regulatory assistance

          2. 56. Regulatory assistance – same manufacturer

       7. PART 7 Relevant Substances

          1. 57. Substances listed for the purposes of paragraph 24(2)(b) and (4)(b) and 37(2)(b)

    3. SCHEDULE 3

       Fees for inspections

       1. 1. General provisions relating to fees for inspections

       2. 2. Fees: general

       3. 3. Traditional herbal medicinal products

       4. 4. Sites concerned with starting materials for traditional herbal medicinal products

       5. 5. Wholesale dealer's licence: general

       6. 6. Wholesale dealer's licence: traditional herbal medicinal products

       7. 7. Wholesale dealer's licences: inspection of short duration

       8. 8. Broker's registrations

       9. 9. Active substance registrations

       10. 10. Office-based inspections

    4. SCHEDULE 4

       Periodic fees for licences

       1. PART 1 Interpretation

          1. 1. In this Schedule— “anthroposophic product” means a medicinal product prepared...

       2. PART 2 Value of the Product Sold or Supplied

          1. 2. Determining the total value of the product

          2. 3. Manufacturer's prices

          3. 4. Information requirements

       3. PART 3 Periodic Fees for Marketing Authorisations and Licences

          1. 5. Marketing authorisations

          2. 6. Marketing authorisation: where Part 2 of the Act applies

          3. 7. Marketing authorisation: derivatives

          4. 8. Number of fee periods

          5. 9. Authorisation for two or more kinds of medicinal product

          6. 10. Reduced fees

          7. 11. Manufacturer's licences or manufacturing authorisations

          8. 12. Wholesale dealer's licences

          9. 13. Wholesale dealer's licences: evidence

          10. 14. Wholesale dealer's licences: special medicinal products

          11. 15. Additional amount for manufacturer's licences and wholesale dealer's licences which relate to special medicinal products

          12. 16. Traditional herbal registrations

       4. PART 4 Types of Marketing Authorisation for which only One Periodic Fee is Payable

          1. 17. Parallel import licences

    5. SCHEDULE 5

       Fees for certificates of registration

       1. . . . . . . . . . ....

    6. SCHEDULE 6

       Time for payment of capital fees: small companies

       1. 1. Interpretation

       2. 2. Major application

       3. 3. Complex application

       4. 4. Multiple application

       5. 5. Outgoing mutual recognition application

       6. 6. Application for traditional herbal registration

       7. 7. Traditional herbal registration: complex variation

       8. 8. Application for manufacturer's licence, manufacturing authorisation or wholesale dealer's licence

       9. 9. Inspection fees in connection with applications

    7. SCHEDULE 7

       Waiver, reduction or refund of capital fees

       1. 1. Interruptions of manufacture, assembly, sale or supply

       2. 2. Reclassification

       3. 3. Variation of a traditional herbal registration

       4. 4. Withdrawal of application in relation to marketing authorisation, traditional herbal registration or clinical trial authorisation

       5. 5. Withdrawal of application in relation to a certificate of registration

       6. 6. Withdrawal of application in relation to manufacturing authorisation, wholesale dealer's licence, manufacturer's licence, broker's registration or active substance registration

       7. 7. Refusal of application for grant of marketing authorisation, traditional herbal registration or clinical trial authorisation

       8. 8. Parallel import licence

       9. 9. Surrender of marketing authorisation at same time as a variation application

       10. 10. Clinical trial authorisation

       11. 11. Scientific advice: paediatric indications

       12. 12. Refunds: treated as having been paid on account

    8. SCHEDULE 8

       Adjustment, reduction or refund of periodic fees

       1. 1. Refund on surrender or revocation of authorisation, registration or licence

       2. 2. Adjustment and refund: licences relating to imported special medicinal products

       3. 3. Refunds: treated as having been paid on account

    9. SCHEDULE 9

       Further revocations

       1. . . . . . . . . . ....

20. Explanatory Note